Influence of Aerobic Exercise and HIIT on Glycemic Control in Adult Men With Type 1 Diabetes (TAILOR/1b) - Trial NCT06080542
Access comprehensive clinical trial information for NCT06080542 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Valencia and is currently Completed. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Valencia
Timeline & Enrollment
N/A
Feb 01, 2023
Jul 15, 2023
Primary Outcome
Blood glucose Glucose control,Interstitial glucose
Summary
Physical exercise is one of the main recommendations included in clinical guidelines for
 people with type 1 diabetes (T1D) because it is associated with substantially lower
 cardiovascular and overall mortality risks. Adherence to regular physical activity is low in
 the T1D population due to factors like time limitations, no access to appropriate equipment
 at home, or economic costs. High-intensity interval training (HIIT) has been proposed as a
 time-efficient methodology, consisting of sessions of short duration and high intensity
 exercises. An easier and cheaper training alternative for HIIT is exercising with elastic
 bands, either in a clinic or at home. Even so, training with elastic bands in T1D in
 combination with the HIIT method has not been compared to aerobic training. Besides, it is
 necessary to understand the glycemic impact of both kinds of exercise in order to build
 better artificial pancreas systems able to deal with exercise automatically. The aim of the
 study will be to determine the impact of aerobic exercise versus high-intensity interval
 training (HIIT) exercise on glycemic control.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06080542
Non-Device Trial